CN106037759A - Cerebral self-adjusting index detection method for sleep apnea - Google Patents
Cerebral self-adjusting index detection method for sleep apnea Download PDFInfo
- Publication number
- CN106037759A CN106037759A CN201610505040.0A CN201610505040A CN106037759A CN 106037759 A CN106037759 A CN 106037759A CN 201610505040 A CN201610505040 A CN 201610505040A CN 106037759 A CN106037759 A CN 106037759A
- Authority
- CN
- China
- Prior art keywords
- slen
- prime
- correlation coefficient
- sigma
- carindex
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 201000002859 sleep apnea Diseases 0.000 title claims abstract description 29
- 238000001514 detection method Methods 0.000 title claims abstract description 11
- 230000002490 cerebral effect Effects 0.000 title abstract 5
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims abstract description 30
- 229910052760 oxygen Inorganic materials 0.000 claims abstract description 30
- 239000001301 oxygen Substances 0.000 claims abstract description 30
- 239000008280 blood Substances 0.000 claims abstract description 29
- 210000004369 blood Anatomy 0.000 claims abstract description 29
- 238000002329 infrared spectrum Methods 0.000 claims abstract description 6
- 238000005070 sampling Methods 0.000 claims abstract description 4
- 210000004556 brain Anatomy 0.000 claims description 37
- 230000000287 tissue oxygenation Effects 0.000 claims description 17
- 230000006870 function Effects 0.000 claims description 12
- 230000011218 segmentation Effects 0.000 claims description 12
- 230000006378 damage Effects 0.000 claims description 10
- 238000012545 processing Methods 0.000 claims description 10
- 101100478210 Schizosaccharomyces pombe (strain 972 / ATCC 24843) spo2 gene Proteins 0.000 claims description 8
- 230000009711 regulatory function Effects 0.000 claims description 5
- 230000008520 organization Effects 0.000 claims description 3
- 238000004364 calculation method Methods 0.000 claims description 2
- 238000000034 method Methods 0.000 abstract description 12
- 238000007781 pre-processing Methods 0.000 abstract 1
- 230000007958 sleep Effects 0.000 description 7
- 230000007547 defect Effects 0.000 description 5
- 238000012544 monitoring process Methods 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 208000029028 brain injury Diseases 0.000 description 2
- 230000003727 cerebral blood flow Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000000306 recurrent effect Effects 0.000 description 2
- 230000000241 respiratory effect Effects 0.000 description 2
- 230000029058 respiratory gaseous exchange Effects 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 238000004566 IR spectroscopy Methods 0.000 description 1
- 206010041235 Snoring Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000004872 arterial blood pressure Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000006931 brain damage Effects 0.000 description 1
- 231100000874 brain damage Toxicity 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000005059 dormancy Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000008713 feedback mechanism Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 230000000004 hemodynamic effect Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 210000003657 middle cerebral artery Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 238000001441 oximetry spectrum Methods 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000003860 sleep quality Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
- A61B5/14551—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters for measuring blood gases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0075—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence by spectroscopy, i.e. measuring spectra, e.g. Raman spectroscopy, infrared absorption spectroscopy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
- A61B5/14551—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters for measuring blood gases
- A61B5/14553—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters for measuring blood gases specially adapted for cerebral tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4806—Sleep evaluation
- A61B5/4818—Sleep apnoea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7203—Signal processing specially adapted for physiological signals or for diagnostic purposes for noise prevention, reduction or removal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7235—Details of waveform analysis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7271—Specific aspects of physiological measurement analysis
- A61B5/7275—Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Medical Informatics (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Surgery (AREA)
- Molecular Biology (AREA)
- Signal Processing (AREA)
- Psychiatry (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Physiology (AREA)
- Artificial Intelligence (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Optics & Photonics (AREA)
- Neurology (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
Abstract
The invention discloses a cerebral self-adjusting index detection method for sleep apnea. The detection method comprises five steps: 1, conducting such pre-processing as denoising, down-sampling and the like on tissue blood oxygen and pulse blood oxygen which are acquired by virtue of a near-infrared spectrum recorder; 2, calculating a moving correlation coefficient r of the tissue blood oxygen and the pulse blood oxygen; 3, conducting segmented weighting on the obtained moving correlation coefficient, so that a weighted moving correlation coefficient wr is obtained; 4, calculating a weighted average of the weighted moving correlation coefficient, so that a cerebral self-adjusting index CARindex is obtained; and 5, assessing the influence of the sleep apnea on a cerebral self-adjusting function in accordance with the cerebral self-adjusting index. The detection method disclosed by the invention can effectively avoid shortcomings of an existing method which is complex in data acquisition, difficult to operate and the like.
Description
Technical field
The invention belongs to processing of biomedical signals technical field, particularly to utilize near-infrared spectrum technique calculate based on
The brain self-regulation index of brain oximetry data evaluates a kind of method that sleep apnea is dangerous.
Background technology
Low blood oxygen and high carbon acid can be caused when suffering from the patient respiratory time-out recurrent exerbation of sleep apnea syndrome, can
Cause maladjusted nervous system, endocrine regulation and hemodynamic change, cause the damage of whole body multiple organ, serious threat people
Healthy.Clinical research confirmation, it is closely related with multiple fatal disease, including apoplexy, hypertension, coronary artery disease
Sick etc..
Sleep analysis monitor (Polysomnography, PSG) is the gold mark of current diagnosis sleep apnea syndrome
Accurate.By the record patient's multinomial physiological parameter in sleep procedure, including electroencephalogram, electrocardiogram, electromyogram, mouth and nose respiratory gas
Stream, the sound of snoring, blood oxygen saturation, heart rate, position, chest and abdomen breathing etc., utilize professional software to be analyzed these parameters, slept
The final reports such as dormancy structure, disordered breathing, sleep monitor.But sleep analysis monitor has following defects that
1, monitoring process need to be carried out at the laboratory of specialty;
2, inspection needs synchronization to carry out long-time multinomial physiology monitoring, and patient needs whole body to stick big quantity sensor, and this is to trouble
The sleep quality of person has certain impact, thus causes monitoring of environmental and true environment difference relatively big, affects the accurate of monitoring result
Property;
3, check expensive;
4, the order of severity of sleep apnea syndrome is only diagnosed by sleep analysis monitor, can not directly assess
The degree of injury of brain in patients self-regulating function.
In the case of the brain self-regulating function of people is int, apneic generation can cause pulse blood oxygen to reduce, for
Maintaining the normal level of providing brain with oxygen, tissue oxygenation can be stablized at certain model under brain self-regulating negative feedback mechanism effect
Enclose.But the apneic recurrent exerbation of extended sleep can make brain self-regulating function impaired, between pulse blood oxygen and tissue oxygenation
Negative feedback will gradually weaken and even disappear, and the power of negative feedback and brain damage degree have substantial connection.
The method that brain self-regulating function is affected by assessment sleep apnea syndrome at present is mainly: use many through cranium
Pu Le (trancranial Doppler, TCD) technology, by calculating average cerebral blood flow velocity (cerebral blood flow
Velocity, CBFV) and the mobile correlation coefficient of arteriotony (arterial blood pressure, ABP), obtain one
The brain index from main regulation can be assessed.
But there is following defect in the method:
1, transcranial doppler need doctor at other operating instrument, and the region that middle cerebral artery to be guaranteed is irradiated by sound wave
Constant diameter, so this acquisition method can not obtain the long-time data during sleep apnea syndrome patient sleeps.
2, arteriotony measurement generally requires employing invasive mode, and for sleep-apnea, patient uses invasive blood pressure
Metering system is unpractical.
Summary of the invention
In order to overcome above-mentioned existing methodical defect, it is an object of the invention to provide a kind of towards sleep apnea
Brain self-regulation index detection method, utilizes near-infrared spectrum technique, is calculated from the brain near infrared light spectrum signal gathered
Tissue oxygenation and pulse blood oxygen signal, between period of sleep apnea, pulse blood oxygen has and to a certain degree reduces, and now brain is certainly
Regulating power will directly be reflected in tissue oxygenation signal, tissue oxygenation signal moves weighting to pulse blood oxygen signal relevant
The calculating of coefficient, finally gives brain self-regulation index, to assess sleep apnea syndrome to brain self-regulating function
Impact, utilizes the method can be prevented effectively from the defects such as existing method data acquisition complexity, operating difficulties.
In order to achieve the above object, the technical solution used in the present invention is:
A kind of brain self-regulation index detection method towards sleep apnea, comprises the following steps:
Step one: near infrared spectrum recorder is gathered detection object night tissue oxygenation with pulse blood oxygen number
According to, carrying out denoising, down-sampled pretreatment, pretreated tissue oxygenation signal is expressed as a length of with pulse blood oxygen signal
Discrete-time series rso2 (n) of N and spo2 (n);Afterwards the data handled well are sent to processing unit;
Step 2: processing unit computation organization blood oxygen and the mobile correlation coefficient of pulse blood oxygen
(1), determine the movable length mLen of mobile segmentation, segment length sLen and segments nesg, see formula (1)~
(3):
SLen=3*mLen (2)
Wherein,
fsSignal sampling rate;
f0Required minimum frequency resolution;
Rounding operation downwards;
(2), calculate the mobile correlation coefficient r (i) that each signal subsection is corresponding, see formula (4):
Wherein,
spo2i(n) and rso2iN () spo2 (n) and i-th segmentation of rso2 (n), be expressed as follows:
spo2i(n)=spo2 (n), mLen* (i-1)+1≤n≤mLen* (i-1)+sLen (5)
rso2i(n)=rso2 (n), mLen* (i-1)+1≤n≤mLen* (i-1)+sLen (6)
L (... ...) sum of products of mean deviations (or sum of sguares of deviation from mean) computing, computing formula is as follows:
Wherein,
The length of m x Yu y;
WithThe average of x Yu y;
(3), the weight w that each signal subsection is corresponding is calculatedp(i) and wr(i), weight computing in step 4, see formula
(8) with (9):
Wherein,
WithThe i-th block signal average of spo2 (n) and rso2 (n), is calculated as follows:
Step 3: step 2 obtain mobile correlation coefficient be r=[r (1), r (2) ..., r (nseg)], corresponding two groups
Weights are wp=[wp(1),wp(2),...,wp] and w (nseg)r=[wr(1),wr(2),...,wr(nseg)], weights pair are used
Mobile correlation coefficient weighted calculates and moves weighted correlation coefficient wr:
(1), to mobile correlation coefficient segmentation, determine segments nseg ', see formula (12) and (13):
SLen '=300*f0 (12)
Wherein,
Every section of segment length of sLen ' segmentation;
(2), calculate every section of corresponding weighting and move correlation coefficient wr (j), see formula (14):
Wherein,
The correlation coefficient weights that w (j) jth segmentation is corresponding, computing formula is as follows:
Wherein,
Max (... ...) take higher value computing;
Step 4: previous step obtains mobile weighted correlation coefficient wr, and it is asked weighted average calculation brain self-regulation index
CARindex, is shown in formula (16):
If CARindex > 1, then CARindex=1;If CARindex <-1, then CARindex=-1;
Step 5: processing unit sends signals below prompting, CARindex ∈ [-1,1]: work as CARindex to display unit
When≤0, send brain self-regulating function and be without damage;As CARindex > 0 time, more level off to 1, send sleep apnea and combine
Close the harm of disease regulatory function autonomous to brain the biggest;More level off to 0, send sleep apnea syndrome to brain from main regulation
Function harm is the least.
The invention have the advantage that and the detecting sphygmus and blood oxygen saturation that cause because of sleep apnea is declined, with by brain from
The change of the tissue oxygenation saturation of regulation connects, and method easy when using noinvasive long obtains initial data, it is to avoid
Traditional method can only gather and the defect of complexity the short time.
Move correlation coefficient by calculating the weighting of pulse blood oxygen and tissue oxygenation, obtain reflecting that sleep apnea is to greatly
The brain self-regulation index of brain self-regulating function influence degree, thus utilize brain self-regulation index to evaluate sleep apnea
Dangerous.
Accompanying drawing explanation
Fig. 1-a is the time domain beamformer of pulse blood oxygen and tissue oxygenation primary signal.
Fig. 1-b is the part-time sectional drawing of pulse blood oxygen and tissue oxygenation primary signal.
Fig. 2-a is through denoising and down-sampled pretreated time domain beamformer.
Fig. 2-b is through denoising and down-sampled pretreated part-time sectional drawing.
Fig. 3-a is the mobile correlation coefficient figure of pulse blood oxygen and tissue oxygenation.
Fig. 3-b is the part-time sectional drawing of pulse blood oxygen and tissue oxygenation.
Fig. 4 is the mobile weighted correlation coefficient figure of pulse blood oxygen and tissue oxygenation.
Fig. 5 is the flow chart of the present invention.
Specific embodiment
Below in conjunction with the accompanying drawings and the present invention is described in detail by example.
Suffer from sleep apnea syndrome patient as data sample with one, gather near infrared light spectrum signal at night, number
According to duration 8 hours 8 points 56 seconds (from 19:53:00 04:01:56), sample rate 10Hz, 293360 points of data length.According to closely
Infrared spectroscopy signals calculates pulse blood oxygen and tissue oxygenation data.Primary signal time domain beamformer and part sectional drawing such as Fig. 1-a with
Shown in Fig. 1-b.In order to assess the impact of the sleep apnea syndrome of this patient regulatory function autonomous on its brain, use this
Data are analyzed by invention.
A kind of brain self-regulation index detection method towards sleep apnea, with reference to Fig. 5, comprises the following steps:
Step one: the signal own situation gathered according near infrared spectrum recorder, carries out denoising and down-sampled to it
Deng pretreatment, after pretreatment, signal sampling rate is 0.2Hz, and data length is 5268 points.Time domain plethysmographic signal figure after pretreatment
And part sectional drawing is as shown in Fig. 2-a and Fig. 2-b, afterwards the data handled well is sent to processing unit;
Step 2: processing unit computation organization blood oxygen and the mobile correlation coefficient r of pulse blood oxygen
Required minimum frequency resolution f0=0.1Hz, obtains according to formula (1)~(3), the movable length of mobile segmentation
MLen=2, segment length sLen=6 and segments nesg=2632;The movement that each signal subsection is corresponding is calculated according to formula (4)
Correlation coefficient r (i).Finally, mobile correlation coefficient r is obtained, as shown in Figure 3.
Step 3: calculate mobile weighted correlation coefficient wr.
According to formula (12) and (13) mobile correlation coefficient carried out segmentation, segment length sLen '=30, segments nseg '=
85;Calculate corresponding weight value according to formula (15), finally obtain mobile weighted correlation coefficient wr according to formula (14), as shown in Figure 4.
Step 4: correlation coefficient wr mobile to weighting asks weighted average to obtain brain self-regulation index CARindex.
The brain self-regulation index CARindex=0.7773 of this patient can be calculated according to formula (16).
Step 5: processing unit sends signals below prompting, CARindex ∈ [-1,1]: work as CARindex to display unit
When≤0, send brain self-regulating function and be without damage;As CARindex > 0 time, more level off to 1, send sleep apnea and combine
Close the harm of disease regulatory function autonomous to brain the biggest;More level off to 0, send sleep apnea syndrome to brain from main regulation
Function harm is the least.The sample data brain self-regulation index of this patient is 0.7773, shows sleep apnea syndrome pair
The damage of its brain self-regulating function is the biggest.
Claims (1)
1. the brain self-regulation index detection method towards sleep apnea, it is characterised in that comprise the following steps:
Step one: near infrared spectrum recorder is gathered detection object night tissue oxygenation with pulse blood oxygen data, enter
Row denoising, down-sampled pretreatment, pretreated tissue oxygenation signal and pulse blood oxygen signal be expressed as a length of N from
Dissipate time series rso2 (n) and spo2 (n);Afterwards the data handled well are sent to processing unit;
Step 2: processing unit computation organization blood oxygen and the mobile correlation coefficient of pulse blood oxygen
(1), determine the movable length mLen of mobile segmentation, segment length sLen and segments nesg, see formula (1)~(3):
SLen=3*mLen (2)
Wherein,
fsSignal sampling rate;
f0Required minimum frequency resolution;
Rounding operation downwards;
(2), calculate the mobile correlation coefficient r (i) that each signal subsection is corresponding, see formula (4):
Wherein,
spo2i(n) and rso2iN () spo2 (n) and i-th segmentation of rso2 (n), be expressed as follows:
spo2i(n)=spo2 (n), mLen* (i-1)+1≤n≤mLen* (i-1)+sLen (5)
rso2i(n)=rso2 (n), mLen* (i-1)+1≤n≤mLen* (i-1)+sLen (6)
L (... ...) sum of products of mean deviations (or sum of sguares of deviation from mean) computing, computing formula is as follows:
Wherein,
The length of m x Yu y;
WithThe average of x Yu y;
(3), the weight w that each signal subsection is corresponding is calculatedp(i) and wr(i), weight computing in step 4, see formula (8) with
(9):
Wherein,
WithThe i-th block signal average of spo2 (n) and rso2 (n), is calculated as follows:
Step 3: step 2 obtain mobile correlation coefficient be r=[r (1), r (2) ..., r (nseg)], two groups of corresponding weights
For wp=[wp(1),wp(2),...,wp] and w (nseg)r=[wr(1),wr(2),...,wr(nseg)], use weights to movement
Correlation coefficient weighted calculates mobile weighted correlation coefficient wr;
(1), to mobile correlation coefficient segmentation, determine segments nseg ', see formula (12) and (13):
SLen '=300*f0 (12)
Wherein,
Every section of segment length of sLen ' segmentation;
(2), calculate every section of corresponding weighting and move correlation coefficient wr (j), see formula (14):
Wherein,
The correlation coefficient weights that w (j) jth segmentation is corresponding, computing formula is as follows:
Wherein,
Max (... ...) take higher value computing;
Step 4: previous step obtains mobile weighted correlation coefficient wr, and it is asked weighted average calculation brain self-regulation index
CARindex, is shown in formula (16):
If CARindex > 1, then CARindex=1;If CARindex <-1, then CARindex=-1;
Step 5: processing unit sends signals below prompting, CARindex ∈ [-1,1]: when CARindex≤0 to display unit
Time, send brain self-regulating function and be without damage;As CARindex > 0 time, more level off to 1, send sleep apnea syndrome
Regulatory function autonomous to brain harm is the biggest;More level off to 0, send sleep apnea syndrome regulatory function autonomous to brain
Endanger the least.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610505040.0A CN106037759B (en) | 2016-06-30 | 2016-06-30 | A kind of brain self-regulation index detection method towards sleep apnea |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610505040.0A CN106037759B (en) | 2016-06-30 | 2016-06-30 | A kind of brain self-regulation index detection method towards sleep apnea |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106037759A true CN106037759A (en) | 2016-10-26 |
CN106037759B CN106037759B (en) | 2018-11-09 |
Family
ID=57201352
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610505040.0A Active CN106037759B (en) | 2016-06-30 | 2016-06-30 | A kind of brain self-regulation index detection method towards sleep apnea |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106037759B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112006652A (en) * | 2019-05-29 | 2020-12-01 | 深圳市睿心由科技有限公司 | Sleep state detection method and system |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080064965A1 (en) * | 2006-09-08 | 2008-03-13 | Jay Gregory D | Devices and methods for measuring pulsus paradoxus |
CN201912276U (en) * | 2010-11-29 | 2011-08-03 | 邱晨 | Pillow type curing, screening and monitoring system for obstructive sleep apnea hyponea syndrome |
WO2012024106A2 (en) * | 2010-08-17 | 2012-02-23 | University Of Florida Research Foundation, Inc. | Central site photoplethysmography, medication administration, and safety |
CN104545818A (en) * | 2015-01-29 | 2015-04-29 | 吉林大学 | Sleep apnea syndrome detection method based on pulse and blood oxygen signals |
-
2016
- 2016-06-30 CN CN201610505040.0A patent/CN106037759B/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080064965A1 (en) * | 2006-09-08 | 2008-03-13 | Jay Gregory D | Devices and methods for measuring pulsus paradoxus |
WO2012024106A2 (en) * | 2010-08-17 | 2012-02-23 | University Of Florida Research Foundation, Inc. | Central site photoplethysmography, medication administration, and safety |
CN201912276U (en) * | 2010-11-29 | 2011-08-03 | 邱晨 | Pillow type curing, screening and monitoring system for obstructive sleep apnea hyponea syndrome |
CN104545818A (en) * | 2015-01-29 | 2015-04-29 | 吉林大学 | Sleep apnea syndrome detection method based on pulse and blood oxygen signals |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112006652A (en) * | 2019-05-29 | 2020-12-01 | 深圳市睿心由科技有限公司 | Sleep state detection method and system |
CN112006652B (en) * | 2019-05-29 | 2024-02-02 | 深圳市睿心由科技有限公司 | Sleep state detection method and system |
Also Published As
Publication number | Publication date |
---|---|
CN106037759B (en) | 2018-11-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3773155B1 (en) | System and method for non-invasive determination of blood pressure dip based on trained prediction models | |
Surrel et al. | Online obstructive sleep apnea detection on medical wearable sensors | |
Xiao et al. | Wearable heart rate monitoring intelligent sports bracelet based on Internet of things | |
CN108882867B (en) | Biological information analysis device, system, and program | |
EP3358485A1 (en) | General noninvasive blood glucose prediction method based on timing analysis | |
Hwang et al. | Nocturnal awakening and sleep efficiency estimation using unobtrusively measured ballistocardiogram | |
KR100493714B1 (en) | Autonomic function analyzer | |
US9615781B2 (en) | Systems and methods for monitoring depth of consciousness | |
CN105142515A (en) | Method for determining a person's sleeping phase which is favourable for waking up | |
Chacon et al. | A wearable pulse oximeter with wireless communication and motion artifact tailoring for continuous use | |
US20220133156A1 (en) | Cardiopulmonary health monitoring using thermal camera and audio sensor | |
Cimr et al. | Automatic detection of breathing disorder from ballistocardiography signals | |
Liu et al. | Cuffless blood pressure measurement using smartwatches: a large-scale validation study | |
Byfield et al. | Towards robust blood pressure estimation from pulse wave velocity measured by photoplethysmography sensors | |
CN114974566A (en) | Cognitive function assessment method and system | |
CN114587310A (en) | Method for realizing invasive blood pressure waveform estimation based on photoplethysmography | |
CN105266764B (en) | A kind of traditional Chinese medical science pectoral qi assessment device | |
CN106037759B (en) | A kind of brain self-regulation index detection method towards sleep apnea | |
CN113171061B (en) | Noninvasive vascular function assessment method, noninvasive vascular function assessment device, noninvasive vascular function assessment equipment and noninvasive vascular function assessment medium | |
US10251564B2 (en) | Thermal patient signal analysis | |
Alqudah et al. | Multiple time and spectral analysis techniques for comparing the PhotoPlethysmography to PiezoelectricPlethysmography with electrocardiography | |
Gu et al. | Algorithm for evaluating tissue circulation based on spectral changes in wearable photoplethysmography device | |
Li et al. | Noninvasive continuous blood pressure estimation algorithm based on features of pulse waves | |
Bhongade et al. | 1D Convolutional Neural Network for Obstructive Sleep Apnea Detection | |
CN117045216B (en) | Blood index non-invasive medical analysis system based on fuzzy control |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20231228 Address after: Room 705, 7th Floor, Building A3, Nanshan Zhiyuan, No. 1001 Xueyuan Avenue, Xili Street, Nanshan District, Shenzhen City, Guangdong Province, 518055 Patentee after: Shenzhen Ruixinyu Technology Co.,Ltd. Address before: 710049 No. 28, Xianning Road, Xi'an, Shaanxi Patentee before: XI'AN JIAOTONG University |
|
TR01 | Transfer of patent right |